| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.06 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.07 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |